Efficacy and tolerance of an emollient on sleep and quality of life on patients with skin disease with severe xerosis

  • 5min
  • May. 2022
  • Supported by
  • La Roche-Posay
Dry skin is a consequence of an altered skin barrier and a malfunction or deficiency of necessary healthy fats in the top layer of the skin with a high trans epidermal water loss. Severe dryness is frequently associated with itch, pain and even bleeding and therefore interferes with the ability to work or sleep. An emollient with active ingredients including shea butter, niacinamide, thermal spring water,APF (a biomass of Vitreoscilla Filiformis grown in TSW) and microresyl has been developed to restore skin barrier, rebalance microbiome, and prevent the excessive proliferation of staphylococci by fighting against the persistence of bacteria and the creation of biofilm. To evaluate the efficacy and tolerance of the Emollient+ efficacy in monotherapy, we carried an observational study from private consultations data.